The Needle Biopsy Market is chiefly driven by product development and the fall in prices of raw materials and components. The increasing cases of cancers and growing usage of biopsy needles is driving the market. The emergence of needle biopsy is estimated to pose the greatest threat to the Needle Biopsy Market. The Needle Biopsy Market is expected to reach $ 677 million by the end of 2023, this market is projected to be growing at a CAGR of ~ 5.2 % during 2017-2023.
Companies should focus on improving the distribution efficiency to reduce the pressures on prices due to huge market fragmentation. Distributional agreements between large players and advanced products such as multilayer needles will be extremely beneficial.
Needle biopsy offers non-invasive diagnostic tests for detecting cancer as it used liquids such as blood, urine, saliva etc. to detect malignancy. Increasing automation will enhance the capabilities of needle biopsy and it may substitute the needle biopsy procedures. Real time progression of cancers is also possible in needle biopsy which raises the level of threat it possesses to needle biopsy. The falling cost of products due to greater market fragmentation and the emergence of Chinese companies is expected to put additional pressures on prices.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/3830
Global Needle Biopsy Market – Key Players
Key players profiled in the report are
- Boston Scientific Corporation
- Cook Medical
- CareFusion Corporation
- Hologic, Inc.
- Cardinal Health, Inc.
- R. Bard, Inc.
- Möller Medical GmbH
- Becton, Dickinson and Company
- Hakko co. ltd.
- Argon Medical Devices, Inc.
Global Needle Biopsy Market – Segmentation
The global needle biopsy market is segmented on the basis of type and applications. Based on type, the market has been segmented as fine-needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy and image-guided biopsy. Based on the utility, the market has been segmented as disposable and reusable. Based on the applications, the market has been segmented as tumor, infection, inflammation and others.
Global Needle Biopsy Market – Regional analysis
US accounts for the maximum market share due to favorable reimbursement scenarios and greater expenditure on healthcare. The faster market uptake of new technology in the US is also an important driver of the market for global needle biopsy. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is the fastest growing region because of large unmet needs which is led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa are expected to be a laggard due to poor economic and political conditions and poor healthcare penetration.
Browse Complete 110 Pages Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/needle-biopsy-market-3830
Major Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope of the Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312